Novartis AG (ADR) news

   Watch this stock
Showing stories 1 - 10 of about 169   

Articles published

NVS 77.03 -0.03 (-0.04%)
price chart
Bullish Pharma stock today: Novartis AG (ADR)(NYSE: NVS)
Novartis AG (ADR)(NYSE: NVS) will look for medicines that are in earlier stages of development as acquisition price tags climb across the industry.
Novartis AG (ADR) (NYSE:NVS) Shares Rise Despite Mixed Results  Stock Market Daily
Novartis AG (ADR) (NVS) Releases Earnings Results, Beats Expectations By $0 ...  Highland Mirror
Stock's Buzzers Gulfport Energy Corporation (NASDAQ:GPOR), Novartis AG (ADR ...
Shares of Novartis AG (ADR) (NYSE:NVS) inclined 0.96% to $77.06. Stock exchanged hands with the total volume of 3.73.
Here's Why You Should Buy Novartis AG (ADR) (NYSE:NVS)
Although Swiss pharmaceutical company Novartis AG (ADR) (NYSE:NVS) missed analysts' expectations on its fourth quarter report, the company is in a strong position due to its diversified business model and product pipeline.
Novartis AG (ADR) (NVS) is Upgraded by Societe Generale to ” Buy”  Highland Mirror
Novartis AG (ADR) (NYSE:NVS) Denies It Is Selling Its Portfolio of Respiratory ...
Novartis AG (ADR) (NYSE:NVS) has denied reports that it intends to sell off some of its drugs that are used in the treatment of COPD and asthma.
Xencor Inc (NASDAQ:XNCR) to Collaborate with Pharma Giant Novartis AG (ADR ...
Xencor Inc (NASDAQ:XNCR) shares rose 32.06% to $16.56 on Tuesday after the company officially signed its collaboration agreement with Novartis AG (ADR) (NYSE:NVS), which has agreed to pay $150 million to have access to Xencor's top two product ...
Novartis Considering Sale Of Alcon Unit After Mixed Q4 Results And Outlook
In perhaps the biggest news stemming from the report, Novartis noted is considering strategic options for the consumer eye care Alcon Division.
Novartis AG (ADR): Why NVS Stock Is Ready to Rebound  Income Investors
Ionis Pharmaceuticals Inc (IONS), Akcea Strike Favorable Deal with Novartis AG ...
Ionis Pharmaceuticals Inc (NASDAQ:IONS) shares were initially up 6% this morning after the biotech firm and its wholly-owned subsidiary Akcea Therapeutics signed an exclusive cardiovascular disease treatment collaborative agreement with Novartis AG ...
Novartis in $1.6 bln deal for Ionis, Akcea drugs  MarketWatch
Novartis AG (ADR) (NYSE:NVS) Says A Picture Is Worth A Thousand Words
How do you mix medicine and photography? That's what Novartis AG (ADR) (NYSE:NVS) is doing and it feels nothing strange about it.
Novartis AG (NYSE:NVS) Fights for Survival after Patent Expiration  TCC
Investor's Watch List Baidu Inc (ADR) (NASDAQ:BIDU), Novartis AG (ADR) (NYSE:NVS)
On Tuesday, Baidu Inc (ADR) (NASDAQ:BIDU) stock opened its trade at $182.86 and after floating in a range of $182.33 to $187.50, settled at $186.99.
Here's What The Novartis AG (ADR) (NYSE:NVS) Deal Means For Conatus ...
Conatus Pharmaceuticals Inc (NASDAQ:CNAT) just announced that it has inked a deal with pharma giant Novartis AG (ADR) (NYSE:NVS); a deal that will see the latter team up with the microcap on the development of a drug called Emricasan. It's a NASH ...
Novartis AG (ADR) (NVS) Agrees To $50 Million Deal With Conatus ...  Insider Monkey (blog)
Conatus shares skyrocket after Novartis license deal  MarketWatch